Oncotarget is a medical journal that provides information to both doctors and ordinary people to understand the treatment, analysis, and prevention of cancer. Primarily it talks all about oncology, a branch of medicine that deals with the prevention, treatment, and analysis of cancer. Impact journal published the journal, and it was launched in 2010.
The first chief editors of Impact journal were Mikhail Blagosklonny and Andrei V. Gudcov. They are currently working at Rosewall Park Cancer Institute. The medical journal is significantly important because it offers resourceful scientific analysis. It also provides help to people who are either affected or infected to have a better understanding to fight and handle the disease. In 2015, oncotarget was ranked number one among the many oncology journals in the States.
The primary aim of oncotarget is to become one of the best medical researchers in oncology. The medical journal, oncotarget published an article in 2015 that proved to be helpful. They called the report the impact of HuR impediment by the small molecule MS-444 on cancer cells. The condition, cancer is one of the deadly diseases present currently more particularly its branch collateral cancer is ranked third as the best cancer that causes death. Since Oncortaget was established, it has acted as a platform where people share important ideas to generate possible solutions.
The most important aspect about the medical journal is that it plays a very significant role in directing the people to understand oncology. The medical research journal helps people to get more information on the prevention and treatment of collateral cancer. Visit Oncotarget’s profile page at facebook.com